Default company panoramic image
895f5fe6 0473 4c10 92ef a1a758eba6cf

Carlsbad Pharmaceuticals, Inc.

CPI has developed a drug discovery platform that will initially be focused on pancreatic and liver cancer.

  • Stage Concept Only
  • Industry Biotechnology
  • Location Oceanside, CA, US
  • Currency USD

Company Summary

CPI’s Technology; Initial Focus – CPI has developed a proprietary platform technology that can be applied to improve currently registered nucleoside drugs, nucleosides and nucleotides in clinical development, as well as for discovery of nucleoside di- and triphosphate mimic prodrugs (N2/3PM-PDs) based on entirely novel nucleoside compounds. We are initially focusing our platform on hepatitis C virus (HCV) infections and/or liver cancer.